Evaluation of RC28-E Injection in Diabetic Macular Edema

PHASE2CompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

March 17, 2021

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2023

Conditions
Diabetic Macular Edema
Interventions
BIOLOGICAL

intravitreal injection of RC28-E

a chimric decoy receptor trap fusion protein by dual blockage of VEGF and FGF

BIOLOGICAL

Conbercept

KH902(Conbercept)

Trial Locations (37)

100010

Peking Union Medical College Hospital, Beijing

Unknown

The Second Hospital of Anhui Medical University, Hefei

Beijing Aier Intech Eye Hospital, Beijing

Beijing Hospital, Beijing

Chinese PLA General Hospital, Beijing

Peking University Third Hospital, Beijing

The First Affiliated Hospital of Chongqing Medical University, Chongqing

The Second Affiliated Hospital of Chongqing Medical University, Chongqing

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

Zhongshan Ophthalmic Center of Sun Yat-sen University, Guangzhou

Huizhou Central People's Hospital, Huizhou

The Affiliated Hospital of Guizhou Medical University, Guiyang

The First People's Hospital of Zunyi, Zunyi

CNPC Central Hospital, Langfang

Hebei Eye Hospital, Xingtai

The First Affiliated Hospital of Harbin Medical University, Harbin

Henan Provincial Eye Hospital, Zhengzhou

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

Zhengzhou Second Hospital, Zhengzhou

Renmin Hospital of Wuhan University, Wuhan

Zhongnan Hospital of Wuhan University, Wuhan

The Second Xiangya Hospital of Central South University, Changsha

Xiangya Hospital Central South University, Changsha

The Affiliated Hospital of Inner Mongolia Medical University, Hohhot

The Affiliated Eye Hospital of Nanjing Medical University, Nanjing

Jiangxi Provincial People's Hospital, Nanchang

The Affiliated Eye Hospital of Nanchang University, Nanchang

The Second Hospital of Jilin University, Changchun

Shenyang He Eye Specialist Hospital, Shenyang

The Fourth People's Hospital of Shenyang, Shenyang

People's Hospital of Ningxia Hui Autonomous Region, Yinchuan

Weifang Eye Hospital, Weifang

Yantai Yuhuangding Hospital, Yantai

Shanxi Eye Hospital, Taiyuan

The First Hospital of Shanxi Medical University, Taiyuan

West China Hospital of Sichuan University, Chengdu

Ruian People's Hospital, Rui’an

All Listed Sponsors
lead

RemeGen Co., Ltd.

INDUSTRY

NCT04782115 - Evaluation of RC28-E Injection in Diabetic Macular Edema | Biotech Hunter | Biotech Hunter